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Keywords: Kenya; foot-and-mouth-disease; serotype O FMDV; East Africa; topotype; outbreaks Foot-and-mouth disease (FMD) affects both domestic and wild cloven-hoofed animals such as cattle, pigs, sheep, and goats plus more than 70 species of wildlife (Alexandersen and Mowat, 2005; Thomson et al., 2003) . The disease is clinically characterized by fever, lameness, and vesicular lesionsvesicles on the tongue, feet, snout, and teats of susceptible species (Kitching, 2002) . FMD has been known since the sixteenth century as an important threat in the cattle industry and has continued to is be one of the world's most economically important livestock diseases . Losses due to FMD can bewith indirect losses due to trade embargos embargos on livestock and livestock products or and direct oneeffects such as reduced milk yields, weight loss, abortions, prenatal mortality and loss of cart power in draught animals (James and Rushton, 2002) . Improved control of the diseasethe disease may contribute to poverty reduction and increased economic growth in developing countries (Perry and Rich, 2007) such as Kenya where the disease is endemic.
The causative agent of the disease, foot-and-mouth disease virus (FMDV), occurs in seven immunologically and genetically distinct serotypes O, A, C, Asia 1, SAT 1, SAT 2, SAT 3 and multiple variants exist within each serotype (Grubman and Morgan, 1986; Knowles and Samuel, 2003) . These serotypes can be distinguishedable both serologically and by nucleotide sequencing. Vaccination against one serotype does not cross-protect against other serotypes, , thus necessitating vaccination against all circulating each of the serotypes circulating. in an area or an outbreak. FurthermoreAdditionally, FMDV has a high potential for genetic and antigenic variation, thishencewhich createsing the need to constantly match vaccines to the circulating field viruses (Domingo et al., 2003) .
The FMDV genome is a positive-sense single-stranded RNA molecule with a length of approximately 8400 nucleotides (nt) long that belongs to the genus Aphthovirus within the Picornaviridae family (Belsham, 2005) . The genome encodes a polyprotein which is processed to the virus structural proteins (SP) designated VP1 (1D), VP2 (1B), VP3 (1C), and VP4 (1A) and multiple non-structural (NS) proteins (Rueckert, 1984) . Within the viral RNA, Tthe VP1 coding region has been found to beis the most variable, hence many studies of evolutionary relationships between FMDV strains and serotypes are based on VP1 sequences have sequenced this part of the genome in order to determine and understand evolutionary relationships between FMDV strains and serotypes (Knowles and Samuel, 2003) , and have. Based on these F o r P e e r R e v i e w O n l y 4 VP1 sequences, the serotypes have been grouped the serotypes into various epidemiologically and genetically distinct regional clusters in different regions of the world defined as virus lineages and topotypes in accordance with intra-lineage and intra-topotype nucleotide identity ≥92.5 % and ≥85%, respectively (Knowles and Samuel, 2003; Samuel and Knowles, 2001a) .
Among the seven serotypes, FMDV O has been found to be dominant globally and has been responsible for some economically devastating outbreaks in countries which are normally free from FMDdisease-free such as the United Kingdom (Knowles et al., 2001; Samuel and Knowles, 2001b) and Japan (Hayama et al., 2012; Sakamoto and Yoshida, 2002) . Similarly, in the region of East Africa (EA) where the disease is endemic, serotype O has been responsible for most outbreaks. Several recent studies have characterized these FMDV O isolates in EA and recommended inclusion of a broader range of virus isolates in future analyses for a better approach to FMD control within the region (Ayelet et al., 2009; Balinda et al., 2010a; Habiela et al., 2010; Kasambula et al., 2012) . These studies found four topotypes of this serotype namely, East Africa 1 (EA-1) to EA-4 circulating in this region with no evidence of additional introductions except for transboundary exchange of viruses between neighbouring countries within the region. In Kenya, most FMDV O strains isolated within the country since 2000 belong to topotypes EA-2, EA-3 and EA-4, while the locally produced vaccine that is currently in use is based on strain O K77/78 which was isolated in 1978 and is classified within topotype EA-1 (Balinda et al., 2010a) . The use of this vaccine may contribute to inadequate disease control, yet the FMD control policy in Kenya is to use locally produced vaccines and animal movement control. So far, the Directorate of Veterinary Services (DVS) has not received complaints or had records of FMDV O post-vaccination outbreaks although it lacks resources to undertake consistent post-vaccination monitoring (PVM). However, it relies on vaccine potency testing results (involving vaccination and challenge), generated by the state vaccine quality control laboratory that is independent from the producer.
Apart from serotype O, other serotypes including A, SAT 1 and SAT 2 have also been recently in circulation (Namatovu et al., 2013) , while previously, serotype C has also been identified within the region (Vosloo et al., 2002) . However, serotype C was last isolated from Kenyan cattle in 2004 (Roeder, 2009; Sangula et al., 2011) . since the year 2000. It was not known whether these were independent outbreaks or if each case was part of a single outbreak that quickly spread to the various districts of the country. In a comparable occurrence, multiple FMD outbreaks were reported to have taken place within a short period of time during [2008] [2009] in neighboring Uganda were shown to belong to a single outbreak that rapidly spread and affected large areas (Kasambula et al., 2012) .
Recently, Balinda et al., (2010a) 
Materials and Methods

Source of viruses used in this study
Epithelial samples were selected from the national FMD laboratory (FMDL), Embakasi, Kenya virus repository. These were field samples collected, from suspected clinical cases of FMD in cattle by goverment District Veterinary Officers (DVOs), between February 2010 and September 2011 for the purpose of serotype identification and mapping to guide FMD control strategies. The samples were preserved in 50% glycerol-phosphate buffered saline (PBS) and transported on ice, in the shortest time possible, to the FMDL, where they were subsequently aliquoted and preserved at -20 o C. Virus isolation in Baby Hamster Kidney (BHK) cells and FMDV antigen detection using enzyme linked immunosorbent assays (ELISAs) were routinely performed according to procedures in the OIE manual (OIE, 2012) . For the purpose of this study, the samples were selected taking regional representation and quality of the material into consideration. Thus samples were selected from different districts representing the eight administrative Table 1 ). The sequences were analysed together with others from a previous study (Balinda et al., 2010a) and from the public sequence databases (Table 1) .
Virus Isolation
At Lindholm and in Pirbright, for the purpose of sequencing, viruses were re-isolated on primary bovine thyroid (BTY) cells according to the OIE manual (OIE, 2012) . Briefly, epithelia preserved in 50% glycerol-PBS at -20°C, were thawed at room temperature, weighed and ground using sterile sand, with a mortar and a pestle, in Eagles minimum essential media supplemented with protein hydrolysate, 2% fetal calf serum and antibiotics to make a 10% suspension. The suspensions were inoculated onto primary bovine thyroid (BTY) cells for 1 hour, followed by a change of media and then continued incubation. The cultures were observed for cytopathic effect (CPE) after 24 and 48 hours and harvested when CPE developed. Negative samples were further passaged onto fresh cells for another 48 hours.
Total RNA Extraction and cDNA Synthesis
At The Pirbright Institute, total RNA extraction and cDNA synthesis were done as described by Ayelet et al. (2009) and Habiela et al. (2010) , while at DTU Vet these were done as follows:
Viral RNA was extracted from CPE positive cell culture harvests using the QIAmp ® viral RNA mini kit (Qiagen) following the viral RNA mini spin protocol as described by the manufacturer, using 60 µl of AVE buffer for elution (as supplied) and the RNA was stored at -80°C.
To synthesize cDNA, the RT master mix was made using PE Biosystems TaqMan RT reagents (part N808-1234) in accordance with the manufacturer's instructions. Briefly, for each reaction, 1.5 µl of 10x TaqMan RT buffer (500 mM KCl, 100 mM TrisHCl, pH 8.3), 3.3 µl of 25 mM MgCl 2 , 3.0 µl of dNTP (2.5 mM each), 0.5 µl of 50 µM random hexamers, 0.3 µl of RNase inhibitor (20U/µl) and 0.375 µl of MultiScribe reverse transcriptase (100 U/µl, Moloney RT) were used making a total of 9 µl per reaction. RNA samples (6 µl) were added to the master mix to make 15 µl per reaction and incubated at 48°C for 45 min, and 95°C
for 5 min. The cDNA products were stored at -20°C. (heat activation of TaqGold) and 50 x ( 95°C 15s and 60°C 60s), then held at 4°C.
RT-PCR to amplify and sequence FMDV VP1 coding sequence
At The Pirbright Institute, these methods were done as described by Ayelet et al. (2009) and Habiela et al.
(2010), while at (DTU Vet) as follows:
Samples which were shown to contain significant amounts of FMDV RNA (Ct <32) (Shaw et al., 2007) were selected for VP1 coding region amplification. The cDNA sequence was amplified using reverse The PCR products (ca. 885 bp) were viewed by electrophoresis on 1.5 % agarose gels (Seakem GTG agarose in 1 X TAE -low EDTA buffer) at 120 volts for 1 hour in parallel with a molecular weight marker ) . Purification of the PCR products was achieved using the QIAquick PCR purification kit (Qiagen). Products for cycle sequencing were quantified using a NanoDrop ® 1000 Spectrophotometer (Thermo Scientific) and for each reaction, 10 -13 ng of amplicon was used. Cycle sequencing, in both directions, was performed using the Big dye Terminator V 3.1 kit (Applied Biosystems) and run on an automated DNA Sequencer (ABI PRISM 3700; Applied Biosystems).
Sequence Analysis
The nucleotide sequences in this study were edited using SeqMan Pro software (Lasergene package, DNAstar, Inc.). Serotypes of the generated sequences were identified and compared with previous data using the Basic Local Alignment Search Tool (BLAST) (www.ncbi.nlm.nih.gov). The sequences were aligned by MUSCLE incorporated in MEGA software version 5.05 (Tamura et al., 2011) and trimmed to 639 nucleotides comprising the complete VP1 coding region.
Substitution models were determined in the MEGA software. Codon positions included were 1st+2nd+3rd.
Maximum Likelihood fits of 24 different nucleotide substitution models were estimated and Akaike Information Criterion (AIC) estimated. Non-uniformity evolution rates were modeled using discrete gamma distribution (G). Thus, Tamura Nei substitution model with gamma distribution and invariable rates (I) (TN93+G+I) was chosen as the best that describes the substitution pattern (Tamura et al.., 2011) . The evolutionary history was inferred using the Neighbor-joining method (Saitou and Nei, 1987 ) and a bootstrap consensus tree estimated from 1000 replicates (Felsenstein, 1985) taken to represent the evolutionary history of the taxa analyzed.
The sequences in this study were compared to selected serotype O Kenyan isolates from 1978 to 2009 and to isolates obtained from neighbouring countries during 1986-2009, using two 1983 isolates from Hong Kong and Indonesia as outgroups. The taxa were grouped into topotypes defined by an intra-topotype nucleotide identity within the VP1 coding sequence of >85% (Knowles and Samuel, 2003; Samuel and Knowles, 2001a) .
Results
Thirty five FMD viruses wereall having been successfully isolated ion celltissue culture and tested positive for serotype O FMDV usingon antigen ELISAs. Virus harvests were also shown to contain significant A, B and C in Fig. 2) . In a Neighbor-joining tree, tThese lineages grouped, in a Neighbor-joining tree, together with viruses from Uganda that had been collected in [2004] [2005] [2006] (Fig. 2) . The one other virus (K72/2010) belonged to the EA-4 topotype (labeled as lineage D in Fig. 2 ), originated from district 14 ( Fig.   1 ) and grouped together with some earlier Ethiopian and Ugandan viruses. This virus made up an independently evolving sub-lineage within this topotype with nucleotide differences of about 11% and 9% compared to the Ethiopian and Ugandan viruses, respectively.
Lineage A, within the EA-2 topotype (Fig. 2) , incorporated nine viruses from this study, including K31/2011 and K249/2010. These viruses had about 97% intra-topotype nucleotide identity within the VP1 coding sequence. They were collected between December 2010 and April 2011 (Table 1) 2009. This lineage also contained three independently evolving sub-lineages ( Fig. 2) with about 6% nucleotide differences among them.
The third lineage (B) within the EA-2 topotype included only one isolate fromin this study (K251/2010) (Fig. 2) . This virus was collected from district 3 in the Western province of the country, near the border with Uganda (Fig. 1) Considering that FMD control measures in Kenya mainly rely on animal movement control and vaccination, and that the virus had spread widely within a short period, it is likely that the control systems in the country were breached during this period. there were loopholes in the control systems in the country at that time. Similarly, lineage C viruses appear to have circulated across three different regions of Kenya 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 By 2008, the EA-2 topotype had been found to be mainly confined to Uganda and Kenya for about ten years (Balinda et al., 2010b) . This study has found that this topotype was the most commonly occurring in
Kenya. This observation is largely consistent with previous studies in the East African region including Ethiopia, Kenya and Uganda (Ayelet et al., 2009; Balinda et al., 2010a) which indicated that recent FMDV O viruses in Kenya and Uganda are all grouped in topotype EA-2 and that there are hardly any incursions from outside the region. Apart from Kenya and Uganda, the EA-2 topotype has also been found in Burundi (1980, 1999 and 2003) , the Democratic Republic of the Congo (2006 and 2010) , Rwanda (1998 and 2004 ), Tanzania (1980 , 1984 , 1985 , 1996 , 1998 , 2004 , northern Malawi (1998) and northern Zambia (2000 and 2010) (N.J. Knowles, unpublished data; Balinda et al., 2010a; Di Nardo et al., 2011) suggesting that EA-2 has been widespread in this region at least since the early 1980's. This is not unexpected as earlier studies have found these countries do rely strongly on one another for livestock trade (Rweyemamu et al., 2008) and pastures especially for the nomadic communities around the national borders. However, studies on the distribution of topotype EA-2 in the region as well as the other topotypes ought to be extended to other countries such as Burundi, Rwanda, Democratic Republic of Congo (DRC), Somalia and South Sudan where the FMD epidemiological situation is unclear Topotype EA-3 was last documented in Kenya in 1999 (KEN/1/1999 and in the same year in Uganda (Balinda et al., 2010a) , while in the recent past it has been mainly confined to Eritrea, Ethiopia and Sudan (Ayelet et al., 2009; Habiela et al., 2010) . However, Di Nardo et al., (2011) Ethiopia (Ayelet et al., 2009) and in Sudan (Habiela et al., 2010) have found that the VP1 coding region of this vaccine which belongs to topotype (EA-1) strain has more than 15% nucleotide divergence, within the VP1 coding region, from the majority of the currently circulating strains. The antigenic relationship between this vaccine strain and FMDV field strains has not been established, yet, as described by Paton et al., (2005) , appropriate vaccine strain selection is essential for FMD control programs that depend on vaccination. Therefore, although vaccination failures have not been recently recorded, there is a need to undertake consistent PVM and vaccine matching.
In conclusion, the existing systems to control the spread of FMDV within Kenya and the entire region of Eastern Africa seem inadequate and require re-evaluation. Therefore, there is need for increased surveillance, better disease control measures at source and efficient animal movement control both within the country and across the borders. Additionally, it is necessary to undertake studies to assess the effectiveness of the current serotype O vaccine strains using virus neutralization tests or ELISAs as recommended by OIE (OIE, 2012). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
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